4.7 Article

Moxifloxacin lethality against Mycobacterium tuberculosis in the presence and absence of chloramphenicol

Journal

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 50, Issue 8, Pages 2842-2844

Publisher

AMER SOC MICROBIOLOGY
DOI: 10.1128/AAC.00250-06

Keywords

-

Funding

  1. NIAID NIH HHS [AI35257, AI063431, R21 AI063431, R01 AI035257] Funding Source: Medline

Ask authors/readers for more resources

The C-8-methoxy fluoroquinolone moxifloxacin was more lethal against chloramphenicol-treated Mycobacterium tuberculosis than Bay y3114, a C-8-H cognate of moxifloxacin, and two C-8-methoxy fluoroquinolones, gatifloxacin and BMS-433368, which have different C-7 substituents. Thus, an optimal combination of C-7 and C-8 substituents is likely to be important for killing nongrowing M. tuberculosis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available